Leukemia stem cells (LSCs) pose a significant challenge in treating acute myeloid leukemia (AML) due to their resistance to ...

"The first thing in my head was, 'Oh my gosh, I don't get to go to Taylor Swift,'" Hannah Everson said of learning her cancer ...

The FDA granted orphan designation to Janssen Research & Development’s bleximenib as a treatment of acute myeloid leukemia, according ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late stage pharmaceutical company with a broad ...

During my second trimester of pregnancy, I started to notice a weird rash, which led to other events before my diagnosis of ...

Researchers have led a global study that identified molecular predictors of survival among Black patients with acute myeloid ...

In the clinical battle against leukemia, recent breakthroughs in chimeric antigen receptor T cells (CAR T) have given ...

In the past decade, we have made significant progress in understanding the biology of acute myeloid leukemia (AML) and ALL, including studying the underlying immune systems at play (3). This has led ...

The FDA granted galinpepimut-S a rare pediatric disease designation for the treatment of pediatric patients with acute ...

In the last decade, tremendous advances have revolutionized the biological landscape of acute myeloid leukemia (AML). The application of sophisticated molecular biology tools has unveiled a plethora ...